Re-evaluating Botox Safety in Treating MS

Botox, or Botulinum toxin has been used as one of the treatments for a number of ailments that included multiple sclerosis. Scientists have discovered that injecting minute quantities of the Botulinum toxin A in overactive muscles result to decreased muscle activity by blocking the release of acetylcholine at the neuromuscular junction. This makes the target muscle unable to contract for a period that can last from four to six months.

For this reason, Botox has been used to treat a variety of conditions, most notably as a treatment for wrinkles. But recently, there have been reports that the use of Botox for treatment may bring with it certain ill effects that have lead to death on several children who have used Botox or a related drug.

This month, the Food and Drug Administration has issued a public alert on Botox and a similar drug called Myobloc and had them linked to some life-threatening symptoms such as strained breathing and a severe difficulty in swallowing which can further lead to a form of pneumonia. The FDA has advised doctors to monitor patients taking the said drug treatments for severe reactions as they decide on whether to strengthen warnings on the drug labels.

The most adverse reactions to the use of Botox treatment has occurred among children who were treated for cerebral palsy associated limb spascity. It is also important to note that the said drugs are not approved y the FDA for use in children as well as adults. As Botox has been popularly used for cosmetic treatments, their use for treating medical conditions such as multiple sclerosis may also be affected.

Although they might prove to be effective in trying to relive some of the symptoms associated with the disease, some adverse reactions that such treatments might cause may be something to consider before MS patients decide on using Botox for treatment. As of the present, further testing may be required in trying to evaluate just how safe Botox may be as a treatment.

 
You can leave a response, or trackback from your own site.